Performance analysis of ANI Pharmaceuticals (ANIP)
Annual Return
Over the past 3 years, ANIP has had an average annual return of +16.17%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, ANIP has had an average annual return of +16.98%, outperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, ANIP has had an average annual return of +3.26%, underperforming the benchmark SPY, which returned +15.44% annual.
Since May 5, 2000, ANIP has had an average annual return of -3.90%, underperforming the benchmark SPY, which returned +8.47% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.71% | +42.80% | +0.27% | +37.06% | -12.68% | +58.67% | -52.91% | +36.93% | -30.13% | +6.31% | +34.31% | -19.96% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| +180.95% | +172.33% | -59.22% | -69.39% | +13.10% | +45.01% | -73.54% | +36.46% | -24.10% | -33.40% | +32.36% | +23.58% |
| 2002 | 2001 | 2000 | |||||||||
| -60.59% | +13.33% | +27.12% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.69% | -9.73% | +4.08% | +3.31% | -1.20% | -4.17% | -4.71% | ||||||
| 2025 | +6.07% | +5.54% | +8.17% | +5.77% | -17.07% | +11.10% | -2.90% | +47.57% | -2.02% | -1.09% | -6.35% | -6.96% | +42.80% |
| 2024 | +1.23% | +21.23% | +2.17% | -4.55% | -1.64% | -1.90% | +3.20% | -3.01% | -6.40% | -4.06% | -0.04% | -3.38% | +0.27% |
| 2023 | +11.19% | -6.46% | -5.08% | -5.03% | +19.65% | +19.25% | -2.37% | +22.55% | -9.83% | +6.33% | -19.33% | +10.70% | +37.06% |
| 2022 | -12.26% | -7.36% | -24.96% | +4.99% | +2.52% | -1.90% | +15.46% | +7.69% | -12.90% | +20.09% | +8.70% | -4.10% | -12.68% |
| 2021 | -1.68% | +1.93% | +24.23% | -7.93% | +3.19% | +2.04% | -3.21% | -10.58% | +8.19% | +13.92% | +10.06% | +11.98% | +58.67% |
| 2020 | +0.55% | -22.58% | -15.13% | -1.77% | -22.40% | +4.17% | -8.47% | +5.88% | -10.03% | -9.64% | +16% | -1.80% | -52.91% |
| 2019 | +19.34% | +22.41% | +7.23% | +0.63% | -1.86% | +17.99% | +2.92% | -22.57% | +11.25% | +7.17% | -21.10% | +0.07% | +36.93% |
| 2018 | +4.22% | -4.62% | -9.12% | +1.93% | +6.66% | +5.54% | +0.22% | -13.07% | -2.85% | -14.16% | +14.53% | -18.99% | -30.13% |
| 2017 | -0.28% | -2.28% | -16.18% | +9.31% | -19.27% | +7.10% | +4.13% | -1.48% | +9.34% | +10.64% | +22.46% | -9.38% | +6.31% |
Drawdown analysis of ANI Pharmaceuticals (ANIP)
The maximum drawdown for the ANIP was -98.81%, occurring on Jun 25, 2013. This drawdown has not yet recovered.
The current ANIP drawdown is -83.28%.
Since May 5, 2000 ANIP has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.81% | Jun 2, 2000 | 3284 | Jun 25, 2013 | Ongoing | Ongoing | Ongoing |
| -18.64% | May 5, 2000 | 14 | May 25, 2000 | 3 | May 31, 2000 | 17 |